View Item 
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UU Student Theses RepositoryBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

        Navigating Barriers to Adequate Vaccination Coverage: Impact of the COVID-19 pandemic and Post-Pandemic Strategies

        Thumbnail
        View/Open
        Impact of the COVID-19 pandemic on Vaccinations and Post-Pandemic Strategies.pdf (1.024Mb)
        Publication date
        2023
        Author
        Molendijk, Ian
        Metadata
        Show full item record
        Summary
        The COVID-19 pandemic disrupted global vaccination programs through various non-pharmacological interventions and posed significant challenges to the administration of childhood vaccinations. This literature review examines the impact of the pandemic on vaccination coverage, emphasizing the decline in coverage ratios and the emergence of vaccine-preventable diseases like measles. It accentuates the importance of addressing barriers to vaccination, including cultural, social, and socioeconomic factors. For example, while higher education and income levels correlate with greater vaccination acceptance, lower educational and income groups only show more vaccine hesitancy but not a higher rate of refusal. Targeted education campaigns are essential to mitigate vaccine hesitancy and improve coverage and should not be limited to specific income or educational groups. This review also highlights the unequal recovery in vaccination coverage across regions and income groups, emphasizing the need for comprehensive strategies to ensure equity in immunization. Most regions returned to (almost) pre-COVID-19 levels of vaccination coverage ratio in 2022, however, when countries were grouped on gross national income, the vaccination coverage ratio of low-income countries was still declining in 2022. People-centred, locally tailored approaches, such as those employed by the GAVI vaccine alliance, offer potential solutions by identifying and addressing low-coverage areas. In the post-pandemic years, efforts to restore and strengthen vaccination programs are crucial, especially with the resurgence of vaccine-preventable diseases. The year 2023, which is deemed "Big Catch-Up", is aligned with the Immunization Agenda 2030 and aims to mitigate the pandemic's consequences and accelerate universal vaccination coverage. The experiences of past outbreaks, such as the Ebola outbreak, underscore the urgency of these efforts. To achieve the Immunization Agenda 2030's ambitious goals and to ensure "no one is left behind", collaborative efforts should be made to increase vaccination coverage and address barriers to immunization uptake. These important steps are necessary to achieve the ultimate goal of adequately protecting the health of children worldwide against vaccine preventable diseases.
        URI
        https://studenttheses.uu.nl/handle/20.500.12932/45635
        Collections
        • Theses

        Related items

        Showing items related by title, author, creator and subject.

        • Background: A non-inferiority (NI) design aims to demonstrate that the experimental arm is not worse than a comparator within a pre-specified margin. A margin of a risk difference of 10% or a Geometric Mean Titer (GMT) ratio from 1.5 to 2.0 is implicitly recommended for vaccine trials. This study explores which NI margins were used in vaccine studies and how they were determined. Methods: A systematic literature search was performed on February 21st, 2013. This resulted in 260 eligible articles, 148 articles were selected randomly; data was collected by the use of a data extraction form. This thesis had an explorative character and therefore descriptive statistics were used to show the determination of the NI margins and which NI margins were used. Results: From the selected articles, 48 were excluded because they did not met the predefined criteria. In 81/100 articles a NI margin on difference was determined. In 71% of reviewed articles a margin of 10% was used, 19% of the articles stated margins lower than 10% (range 3-7.5%), whereas in 10% of the articles margins larger than 10%(range 11.5-50%) were stated as the NI margin. In 55/100 articles a NI margin on the GMT ratio was stated. In 60% of the articles a margin of 0.67/1.5 was used, in 33% the stated margins were 0.5/2.0. A large amount (85%) of the examined articles did not discuss how the NI margin was determined. Only five articles referred to the FDA or EMA guidelines, eight articles referred to methodological articles and two articles referred to previous articles specific for the vaccine. In 82/100 articles the conclusion corresponded to the results, in fourteen the conclusion could not be checked because the effect estimates were not shown, in four articles the conclusion of the authors was not in line with the results. Conclusion: The majority of reviewed articles showed no determination of the NI margin. Not all articles showed all their estimates on NI. Reporting on design and results of NI vaccine trials could therefore be improved. Current guidelines on NI trials contain no explicit margin for vaccine trials. The choice of the NI margin is essential for the outcome of the NI trials, although determination is a great challenge. Regulatory offices might help with presenting guidelines which contain an explicit margin (for a specific vaccine/disease). 

          Donken, R. (2013)
          Background: A non-inferiority (NI) design aims to demonstrate that the experimental arm is not worse than a comparator within a pre-specified margin. A margin of a risk difference of 10% or a Geometric Mean Titer (GMT) ...
        • Cancer Vaccinations; The different vaccine types and the treatment results of melanoma and prostate cancer vaccines 

          Pallast, M. (2015)
          Objective – The conventional methods of treating cancer are not always effective enough and in both human and veterinary medicine cancer vaccines could be a significant asset. There are many different vaccine types that ...
        • Vaccination or hesitation: A connection between factors that explain COVID-19 vaccine hesitancy and groups of vaccine hesitant individuals in the Netherlands 

          Wilt, Laura de (2022)
        Utrecht university logo